40,95 €
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
40,95 €
40,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
Als Download kaufen
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
Jetzt verschenken
40,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
  • Format: PDF

A detailed examination of China's increasingly important chemical and pharmaceutical industry. Numerous case studies describe how western companies, such as BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing their market entry in China.

Produktbeschreibung
A detailed examination of China's increasingly important chemical and pharmaceutical industry. Numerous case studies describe how western companies, such as BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing their market entry in China.


Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
At detailed look at China s increasingly important chemical and pharmaceutical industry. One central aspect is the political and economic situation in China with its strategic and operational implications for Western chemical and pharma companies. Numerous case examples describe how Western companies, such as BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing their market entry in China. The book also analyzes the threat of Western companies in their home markets by Chinese competitors.
Rezensionen
From the reviews: "China, with its potential market of 1.3 billion consumers, has resurrected the western world's stagnant economic outlook. ... This is an interesting book on the global chemical industry and the business practices of multinational companies." (Helmut Hügel, Chemistry in Australia, December, 2005)